InvestorsHub Logo
Followers 43
Posts 2488
Boards Moderated 0
Alias Born 10/19/2015

Re: None

Monday, 11/29/2021 12:57:22 PM

Monday, November 29, 2021 12:57:22 PM

Post# of 462254
Question for the board: at some point Anavex will lose patent rights for A273. Generics will hit the market when the FDA allows competition. Assuming the clock for Rett begins ticking in 2022 or 2023, would each subsequent NDA for A273 extend the protection, or doesn’t it matter once the drug is approved the first time?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News